FDA Updates Class I Recall Alert For SynCardia's Bridge-To-Transplant System
Executive Summary
SynCardia Systems' Freedom Driver System was subject to a class I recall last year, and now US FDA has updated its concerns about a component of the firm's Temporary Total Artificial Heart based on post-approval study data, and is asking that malfunctioning drivers be returned to the manufacturer.
You may also be interested in...
Carmat To Launch Total Artificial Heart In Early 2021
After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.
Another Class I Recall For HeartWare's HVAD System
Medtronic announced FDA's high-risk designation of recalls from its new subsidiary’s products on Sept. 30. HeartWare products have been subject to a total of nine class I recalls since 2013.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.